Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-27T12:37:43.415Z Has data issue: false hasContentIssue false

P-1066 - Evaluation of Efficacy and Safety of an Occlusal Splint Vs. Gabapentin in the Treatment of Sleep Bruxism

Published online by Cambridge University Press:  15 April 2020

E. Abdollahian*
Affiliation:
Psychiatry and Behavioral Sciences Research Center, Mashhad University of Med. Sciences, Mashhad, Iran

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

The objective of this study was to compare the efficacy and safety of an occlusal splint vs. Gabapentin in the treatment of this problem.

Materials and methods

Twenty subjects with sleep bruxism were divided into occlusal splints and gabapentin treatment groups. Sleep laboratory recordings by polysomnography were made before and 2 months after the interventions to assess the effectiveness of each treatment and in 4 subjects of each group on the third night after two weeks of wash-out, to evaluate the stability of treatment results. Data analysis was done by Harmonie 6.0 software. For statistical analysis, Willcoxon test was used.

Results

Greater reduction in these parameters were found in Gabapentin group.

Occlusal splint was effective in reduction of massetter muscle activity (EMG).

Moreover, the subjects treated with Gabapentin showed a significant improvement in the total sleep time and sleep efficiency.

Conclusion

Gabapentin showed more improvement in duration of bruxism, whereas occlusal splint showed more reduction of massetter muscle contractions during sleep bruxism so Gabapentin can be an effective treatment modality in sleep bruxism especially in those with poor sleep quality.

Type
Abstract
Copyright
Copyright © European Psychiatric Association 2012
Submit a response

Comments

No Comments have been published for this article.